BioLife Solutions Inc (BLFS)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -20,184 | -46,025 | -73,454 | -62,934 | -66,427 | -102,234 | -83,419 | -146,098 | -139,805 | -106,361 | -95,965 | -15,211 | -8,908 | 4,025 | 2,813 | -21,443 | 1,983 | 7,778 | 19,180 | 39,812 |
| Total stockholders’ equity | US$ in thousands | 348,909 | 325,461 | 321,442 | 333,405 | 337,663 | 332,017 | 352,128 | 358,107 | 364,188 | 405,120 | 409,544 | 476,075 | 478,047 | 489,259 | 452,281 | 208,777 | 204,429 | 186,851 | 105,843 | 67,709 |
| ROE | -5.78% | -14.14% | -22.85% | -18.88% | -19.67% | -30.79% | -23.69% | -40.80% | -38.39% | -26.25% | -23.43% | -3.20% | -1.86% | 0.82% | 0.62% | -10.27% | 0.97% | 4.16% | 18.12% | 58.80% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-20,184K ÷ $348,909K
= -5.78%
BioLife Solutions Inc's return on equity (ROE) has shown a significant decline over the past few years. From a high of 58.80% in March 2020, the ROE has deteriorated steadily, dropping to -5.78% by December 2024. This downward trend indicates that the company's ability to generate profits from shareholder equity has weakened over time.
The decreasing ROE may be a cause for concern as it suggests that the company is not effectively utilizing its shareholders' investments to generate returns. Investors and stakeholders should closely monitor this metric to assess the company's profitability and long-term sustainability. The management of BioLife Solutions Inc may need to implement strategic initiatives to improve profitability and enhance shareholder value.
Peer comparison
Dec 31, 2024